Ultrasound contrast agents for molecular imaging

Handbook of Experimental Pharmacology

Volumn 185, Issue PART1, 2008, Pages 223-245

  Hauff, Peter ^a   Reinhardt, Michael ^a   Foster, Stuart ^b  

^a BAYER PHARMA AG   (Germany)

^b Sunnybrook Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ANIMAL; COMPUTER ASSISTED DIAGNOSIS; ECHOGRAPHY; GENETIC PROCEDURES; HUMAN; MICROBUBBLE; REVIEW;

ANIMALS; CONTRAST MEDIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MICROBUBBLES; MOLECULAR PROBE TECHNIQUES; ULTRASONOGRAPHY;

EID: 52049123313     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-72718-7_11     Document Type: Article

References (55)

1. Bauer A, Blomley M, Leen E et al (1999) Liver-specific imaging with SHU 563 A: Diagnostic potential of a new class of ultrasound contrast media. Eur Radiol 9(Suppl 3):S349-S352
2. Berwing K, Schleppe M (1988) Echocardiographic imaging of the left ventricle by peripheral intravenous injection of echo contrast agent. Amer Heart 115:399-408
3. Chiang CW, Lin FC, Fu M et al (1986) Importance of adequate gas-mixing in contrast echocardiography. Chest 89:723-726
4. Choi SH, Kono Y, Corbeil J et al (2004) Model to quantify lymph node enhancement on indirect sonographic lymphography. AJR Am J Roentgenol 183:513-517
5. Christiansen JP, Leong-Poi H, Klibanov AL et al (2002) Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 105:1764-1767
6. Cosgrove D (1996) Warum brauchen wir Kontrastmittel fur den Ultraschall Clin Radiol 51(Suppl 1):1-4
7. Dayton PA, Ferrara KW (2002) Targeted imaging using ultrasound. J Magn Reson Imaging 16:362-377
8. De Jong N (1997) Physics of microbubble scattering. In: Nanda NC, Schlief R, Goldberg BB (eds) Advances in echo imaging using contrast enhancement, 2nd edn. Kluwer, Dordrecht, pp 39-64
9. Ellegala DB, Leong-Poi H, Carpenter JE et al (2003) Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to ?v?3. Circulation 108:336-341
10. Fischer NG, Christiansen JP, Klibanov AL et al (2002) Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 40:811-819
11. Fox RJ, Ransohoff RM (2004) New directions in MS therapeutics: vehicles of hope. Trends Immunol 25:632-636
12. Gramiak R, Shah P (1968) Echocardiography of the aortic root. Invest Radiol 3:356-366
13. Hauff P, Reinhardt M, Jeschke J et al (1994) Indirekte Lymphographie mit einem neuen Ultraschallkontrastmittel (USKM). Ultraschalldiagnostik '94, Drei-Lander-Treffen, Basel, Schweiz, 26-29.10.1994. Bildgebung/lmaging 61(Suppl 2):17
14. Hauff P, Fritzsch T, Reinhardt M et al (1997) Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 32:94-99
15. Hauff P, Stephens A, Brautigam M (2003) New imaging probes. In: Debatin JF, Hricak H, Niendorf HP (eds) MRI: from current knowledge to new horizon. Excerpta Medica, pp 259-268
16. Hauff P, Reinhardt M, Briel A et al (2004) Molecular targeting of lymph nodes with L-selectin ligand-specific us contrast agent: a feasibility study in mice and dogs. Radiology 231:667-673
17. Hauff P, Seemann S, Reszka R et al (2005) Evaluation of gas-filled microparticles and sonoporation as gene delivery system: Feasibility study in rodent tumor model. Radiology 236:572-578
18. KellerMW, GlasheenW, Teja K et al (1988) Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of regional myocardial perfusion. J Amer Coll Cardiol 12:1039-1047
19. Klibanov AL (1999) Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 37:139-157
20. Klibanov AL (2005) Ligand-carrying gas-filed microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjugate Chem 16:9-17
21. Korpanty G, Grayburn PA, Shohet RV et al (2005) Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol 31:1279-1283
22. Lange L, Fritzsch T, Hillmann J et al (1986) Right-heart echocontrast in the anesthetized dog after i.v. administration of a new standardized sonographic agent, 3rd communication: Comparison of various contrast agents employed in contrast echocardiography. Arzneim-Forsch 36: 1037-1040
23. Lanza GM and Wickline SA (2001) Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 44:13-31
24. Lee F and Ginzton L (1983) A central nervous system complication of contrast echocardiography. J Clin Ultrasound 11:292-294
25. Leong-Poi H, Christiansen J, Klibanov AL et al (2003) Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to v-Integrins. Circulation 107:455-460
26. Lindner JR, Coggins MP, Kaul S et al (2000) Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin-and complement-mediated adherence to activated leukocytes. Circulation 101:668-675
27. Lindner JR, Dayton PA, Coggins MP et al (2000) Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 102:531-538
28. Lindner JR, Song J, Xu F et al (2000) Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 102:2745-2750
29. Lindner JR, Song J, Christiansen J et al (2001) Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104:2107-2112
30. Linker R, Reinhardt M, Bendszus M et al (2005) In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J Autoimmunity 25:199-205
31. Maurer M, Linker R, Hauff P et al (2003) Imaging of ICAM-1 in experimental autoimmune enecephalomyelitis (EAE) with a specific ultrasound contrast agent. Neurology 60:A423
32. Maurer M, Linker R, Reinhardt M et al (2005) Moglichkeiten target-spezifischer molekularer Bildgebung mit Ultraschallkontrastmitteln. Radiologe 45:560-568
33. Mattrey RF (1983) Perfluorochemicals as liver-and spleen-seeking ultrasound contrast agents. J Ultrasound Med 2:173-176
34. Mattrey RF, Kono Y, Baker K et al (2002) Sentinel lymph node imaging with microbubble ultrasound contrast Material. Acad Radiol 9(Suppl 1):S231-S235
35. Oussoren C, Zuidema J, Crommelin DJ et al (1997) Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochim Biophys Acta 1328:261-272
36. Reinhardt M, Fritzsch T, Heldmann D et al (1993) Use of microcapsules as contrasting agents in colour Doppler sonography. WO 93/25241
37. Reinhardt M, Hauff P, Linker RA et al (2005a) Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ). Neuroimage 27:267-278
38. Reinhardt M, Hauff P, Briel A et al (2005b) Sensitive Particle Acoustic Quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations. Invest Radiol 40:2-7
39. Rychak JJ et al (2007) Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging 6:289-296
40. Schirner M, Menrad A, Stephens A et al (2004) Molecular imaging of tumor angiogenesis. Ann N Y Acad Sci 1014:67-75
41. Schlief R (1997) Echo-enhancing agents: their physics and pharmacology. In: Nanda NC, Schlief R, Goldberg BB (eds) Advances in echo imaging using contrast enhancement, 2nd edn. Kluwer, Dordrecht, pp 85-113
42. Schrope V, Newhouse VL, Uhlendorf V (1992) Simulated capillary blood flow measurement using a non-linear ultrasonic contrast agent. Ultrasonic Imaging 14:134-158
43. Schumann PA, Christiansen JP, Quigley RM et al (2002) Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 37:587-593
44. Simionescu M (2000) Structural, biochemical and functional differentiation of the vascular endothelium. In: Risau W, Rubanyi GM (eds) Morphogenesis of the endothelium. Harwood, Amsterdam, pp 1-22
45. Simon RH, Ho SY, D'Arrigo J et al (1990) Lipid-coated ultrastable microbubbles as a contrast agent in neuro-sonography. Invest Radiol 25:1300-1304
46. Streeter PR, Rouse BT, Butcher EC (1988) Immunohistologic and functional characterization of a vascular addressing involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 107:1853-1862
47. Takeuchi M, Ogunyanki K, Pandian NG et al (1999) Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies. J Am Soc Echocardiogr 12:1015-1021
48. Tiemann K, Pohl C, Schlosser T et al (2000) Stimulated acoustic emission: pseudo-Doppler shifts seen during the destruction of non-moving microbubbles. Ultrasound Med Biol 26:1161-1167
49. Uhlendorf V, Hoffmann C (1994) Nonlinear acoustic response of coated microbubbles in diagnostic ultrasound. Ultrasonics Symposium, Cannes, France, pp 1559-1562
50. Villanueva FS, Jankowski RJ, Klibanov S et al (1998) Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98:1-5
51. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316-333
52. Weller GER, Lu E, Csikari MM (2003) ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 108:218-224
53. Weller GER,WongMKK,Modzelewski RA et al (2005) Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65:533-539
54. Wright WH, McCreery TP, Krupinski EA et al (1998) Evaluation of new thrombus-specific ultrasound contrast agent. Acad Radiol 5(Suppl 1):S240-S242
55. Wu Y, Unger EC, McCreery TP et al (1998) Binding and lysing of blood clots using MRX-408. Invest Radiol 33:880-885